The Christie NHS Foundation Trust **

Greater Manchester, Cancer Alliance

Management of High Grade Dysplasia patients

Time period: 2015-19
Cancer Alliance National
Number of High Grade Dysplasia patients in audit 17 1448
Cancer Alliance National
Method of Diagnosis
– First diagnosis confirmed by second pathologist 12 69.2% 86.9%
Treatment planning
– HGD plan discussed at MDT 17 100.0% 87.9%
– Treatment plan for active treatment 13 76.5% 81.1%
First treatment
– Endoscopic therapy (such as endoscopic resection) 6 35.3% 73.8%
– Surveillance 1 5.9% 11.0%

Management of oesophago-gastric cancer patients

Time period: 2017-2019
Organisation National
Number of oesophago-gastric (OG) cancer patients in audit N/A 20528
Case ascertainment for OG cancer (%)
Method of Diagnosis
– Patients diagnosed after an emergency admission**
** Percent figure accounts for differences in mix of patients across organisations
N/A 13.3%
– Patients with referral source reported as unknown N/A 1.8%
Pre-treatment staging of cancer
– Patients having staging CT scan recorded N/A 86.9%
Treatment planning
– Patients having a plan for curative treatment N/A 38.5%
– Patients having a plan for non-curative treatment N/A 61.5%
– Patients with non-curative plans having chemotherapy or radiotherapy N/A 48.2%

Download this data as a PDF